MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines—an advance that could lead to much ...

CAR T-cell therapy has been hugely successful in treating certain types of tumours, and stiffening up cancer cells beforehand ...

The first clinical trial to test the tumour-fighting power of a stem-cell-like class of long-lived immune cells suggests that they could be more potent and less toxic than the standard mix of cells ...

Scientists want to know what causes B cells — which direct T cells to attack cancer — to malfunction and how they can be ...

The University of Texas MD Anderson Cancer Center and CTMC, a joint venture between UT MD Anderson and Resilience, today ...

Developing effective immunotherapies for acute myeloid leukemia (AML) has long been hampered by a critical challenge: Therapy directed at killing the leukemia cells may also harm the body's ability to ...

The British biotechnology startup is making "pan-gamma delta” T cell engagers it says can address the limitations of similar, existing therapies.

By Nancy Lapid May 1 (Reuters) - We also report on a new use for artificial intelligence that could help eliminate some racial inequities in heart disease diagnoses. MODIFIED T-CELL THERAPY MAY AVOID ...

Over the last decade, the cellular cancer immunotherapy known as CAR T-cell therapy has roared to the rescue of many blood cancer patients. The engineered immune cells revolutionized treatment of ...

Jurassic Park actor is advocating for CAR T-cell therapy, which he underwent as part of a clinical trial, to be rolled out for blood cancer patients across Australia ...

Every single type of cancer, explained A cancer diagnosis can be both terrifying and confusing for those afflicted, as well ...